SCHEMBL7434698

SCHEMBL7434698

Clc1cccc(CCI)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.63
PNMT P11086 2/20 0.56
ALDH1A1 P00352 1/20 0.54
HPGD P15428 1/20 0.54
ALOX15 P16050 1/20 0.54
ALOX12 P18054 1/20 0.54
CASP1 P29466 1/20 0.54
HSD17B10 Q99714 1/20 0.54
HTR3E A5X5Y0 3/20 0.53
HTR3B O95264 3/20 0.53
HTR3A P46098 3/20 0.53
HTR3D Q70Z44 3/20 0.53
HTR3C Q8WXA8 3/20 0.53
AOC3 Q16853 1/20 0.53
CYP3A4 P08684 2/20 0.50
IDO1 P14902 2/20 0.50
AGXT P21549 2/20 0.50
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
CHRM3 P20309 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14691406 0.87 TAAR1 (0.59) TAAR1PNMTHTR3EHTR3BHTR3A
SCHEMBL12050856 0.85 TAAR1 (0.74) TAAR1PNMTHTR3EHTR3BHTR3A
SCHEMBL23071686 0.84 TAAR1 (0.65) TAAR1PNMTALDH1A1HPGDHTR3E
SCHEMBL22288272 0.83 ALDH1A1 (0.68) TAAR1ALDH1A1HPGDALOX15ALOX12
SCHEMBL15989864 0.82 TAAR1 (0.63) TAAR1PNMTHTR3EHTR3BHTR3A
SCHEMBL1079592 0.82 TAAR1 (0.63) TAAR1PNMTALDH1A1HPGDHTR3E
SCHEMBL30123688 0.81
SCHEMBL6663215 0.81
SCHEMBL5241228 0.81 TAAR1 (0.68) TAAR1PNMTHTR3EHTR3BHTR3A
SCHEMBL31567921 0.79 TAAR1 (0.65) TAAR1PNMTHTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112939841-B Synthesis method of (2S) -2-N-fluorenylmethoxycarbonyl amino-4- (3-chlorophenyl) butyric acid 康化(上海)新药研发有限公司 2024-06-07 CN claimed
CN-112939841-A Synthesis method of (2S) -2-N-fluorenylmethoxycarbonylamino-4- (3-chlorphenyl) butyric acid 康化(上海)新药研发有限公司 2021-06-11 CN claimed
CN-112939841-B Synthesis method of (2S) -2-N-fluorenylmethoxycarbonyl amino-4- (3-chlorophenyl) butyric acid 康化(上海)新药研发有限公司 2024-06-07 CN disclosed
CN-112939841-B Synthesis method of (2S) -2-N-fluorenylmethoxycarbonyl amino-4- (3-chlorophenyl) butyric acid 康化(上海)新药研发有限公司 2024-06-07 CN disclosed
CN-112939841-A Synthesis method of (2S) -2-N-fluorenylmethoxycarbonylamino-4- (3-chlorphenyl) butyric acid 康化(上海)新药研发有限公司 2021-06-11 CN disclosed
CN-112939841-A Synthesis method of (2S) -2-N-fluorenylmethoxycarbonylamino-4- (3-chlorphenyl) butyric acid 康化(上海)新药研发有限公司 2021-06-11 CN disclosed
EP-3332645-A1 USE OF SUBSTITUTED PYRIMIDINE DIONES OR THEIR SALTS AS AGENTS TO COMBAT ABIOTIC PLANT STRESS Bayer Cropscience AG (DE) 2018-06-13 EP disclosed
EP-0771196-B1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 1999-12-08 EP disclosed
US-5717109-A CARBOXYCYCLOPROPYL GLYCINE DERIVATIVES; USEFUL FOR TREATMENT OF ACUTE OR CHRONIC NEURODEGENERATIVE CONDITIONS, AND AS ANTIPSYCHOTIC, ANTICONVULSANT, ANALGESIC, ANXIOLYTIC, ANTIDEPRESSANT AND ANTI-EMETIC AGENTS ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
EP-0771196-A4 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 1997-09-03 EP disclosed
EP-0771196-A1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-05-07 EP disclosed
WO-1996007405-A1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1996-03-14 WO disclosed